Building complex chemical structures in modern medicine and the pharmaceutical industry is a challenging task. In particular, ensuring the correct arrangement of chiral molecules is essential for the efficacy of medicines. A research paper published in the science journal 'Nature' on October 9, 2026, has opened a new possibility in this field. Researchers have successfully produced chiral haloalcohols with high precision using the P450 enzyme as a catalyst.
The specialty of this new process is its 'enantiodivergent' capability. Simply put, scientists can use the same process to build molecules of different orientations, which is very complex to do with traditional chemical methods. Using biocatalysts is expected to have a lower impact on the environment.
The practical importance of this discovery for the pharmaceutical industry is immense. Many chemical processes currently used in the production of expensive medicines are quite costly and create complex by-products. Enzyme-based methods like P450 can make such processes simpler and more cost-effective. This has a strong potential to reduce medicine production costs in the future.
Researchers have demonstrated the experimental success of this technology, which will serve as a strong foundation for industrial-scale application in the future. Experts have expressed the opinion that this combination of biotechnology and chemistry in the field of science will help increase the accessibility of medical products in the coming days.